CoChat

Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*

Ted Wun, MIGUEL CORDOBA, Arun Atreiya Rangaswami, Anthony Cheung, Teresa G. Paglieroni · 2002 · Clinical & Laboratory Haematology
Cited by 130

The DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) increase endothelial surface receptors that mediate the adherence of sickle erythrocytes to the endothelium. Increased circulating levels of these cytokines have been found in patients with sickle cell disease (SCD). Monocytes are a source of both of these inflammatory mediators; we therefore determined whether circulating monocytes were activated in SCD, as defined by intracellular expression of these cytokines. Blood was also assayed for the presence of platelet-monocyte aggregates (PMAs), as platelet adherence is one possible mechanism for monocyte activation. The median percentages of monocytes expressing intracellular TNF-alpha and IL-1beta in SCD patients were 6.8 (2.8-17.3) [median (range)] and 14.1 (1.3-44.8), respectively. In African-American controls the corresponding percentages were 0.3 (0.1-0.5) and 0.4 (0.1-3.0), and in Caucasians 0.2 (0.1-0.5) and 0.8 (0.8-1.9) (P < 0.001, Kruskal-Wallis). The mean percentage (+/- SD) of PMA was 14.0 +/- 8.3 for Caucasian controls, 25.7 +/- 7.3 for African-American controls, and 45.7 +/- 21.6 for patients with SCD (P < 0.001, RM ANOVA; P < 0.05, Newman-Keuls posthoc test). We conclude that there are increased circulating PMAs and monocyte activation in patients with SCD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1046/j.1365-2257.2002.00433.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 44

  1. 1R.J. Adams (1994 ) Neurologic complications . In:Sickle Cell Disease: Basic Principles and Practice(eds S. J. Embury, R. P. Hebbel, N. Mohandas & M. H. Steinberg), pp. 599-621. Raven Press, New York.
  2. Belcher J.D., 2000, Blood, 96, 2451, 10.1182/blood.V96.7.2451 · DOI · Paper page
  3. 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R · DOI · Paper page
  4. Croizat H., 1994, British Journal of Haematology, 87, 592, 10.1111/j.1365-2141.1994.tb08318.x · DOI · Paper page
  5. 10.1046/j.1365-2141.1996.4951036.x · DOI
  6. Fadlon E., 1998, Blood, 91, 266, 10.1182/blood.V91.1.266 · DOI · Paper page
  7. Francis R.B., 1992, Journal of the National Medical Association, 84, 611
  8. Francis R.B., 1991, Blood, 77, 1405, 10.1182/blood.V77.7.1405.1405 · DOI · Paper page
  9. 10.1016/S0735-1097(97)00510-X · DOI · Paper page
  10. Gawaz M., 1995, European Journal of Clinical Investigation, 25, 843, 10.1111/j.1365-2362.1995.tb01694.x · DOI · Paper page
  11. Graido-Gonalez E., 1997, Blood, 90, 26b
  12. Graido-Gonzalez E., 1998, Blood, 92, 2551, 10.1182/blood.V92.7.2551 · DOI · Paper page
  13. Hebbel R.P., 1997, Journal of Clinical Investigation, 99, 2561, 10.1172/JCI119442 · DOI
  14. Hebbel R.P., 1985, Clinical Haematology, 14, 141, 10.1016/S0308-2261(21)00466-5 · DOI
  15. Hebbel R.P., 1997, Journal of Laboratory and Clinical Medicine, 129, 288, 10.1016/S0022-2143(97)90176-1 · DOI
  16. Hendriks J., 1984, Journal of Clinical and Laboratory Immunology, 13, 129
  17. Hofstra T.C., 1996, Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI · Paper page
  18. 10.1046/j.1365-2141.2000.02353.x · DOI · Paper page
  19. 10.1016/0022-1759(93)90158-4 · DOI · Paper page
  20. Kasschau M.R., 1996, Blood, 87, 771, 10.1182/blood.V87.2.771.bloodjournal872771 · DOI · Paper page
  21. Key N.S., 1998, Blood, 91, 4216, 10.1182/blood.V91.11.4216 · DOI · Paper page
  22. Kumar A., 1996, Blood, 88, 4348, 10.1182/blood.V88.11.4348.bloodjournal88114348 · DOI
  23. Lawson C.A., 1997, Journal of Clinical Investigation, 99, 1729, 10.1172/JCI119337 · DOI
  24. Mendoza E., 1991, Acta Haematologica, 85, 199, 10.1159/000204892 · DOI
  25. 10.1016/S0735-1097(96)00164-7 · DOI
  26. Natarajan M., 1996, Blood, 87, 4845, 10.1182/blood.V87.11.4845.bloodjournal87114845 · DOI
  27. 10.1016/S0049-3848(96)00205-8 · DOI
  28. 31D.R. Powars (1994 ) Natural history of disease: the first two decades . In:Sickle Cell Disease: Basic Principles and Practice(eds S. H. Embury, R. P. Hebbel, N. Mohandas & M. H. Steinberg), pp. 395-412. Raven Press, New York.
  29. 10.1080/09537109777113 · DOI
  30. Rinder C.S., 1992, Blood, 79, 1201, 10.1182/blood.V79.5.1201.1201 · DOI · Paper page
  31. Silverstein R.L., 1987, Journal of Clinical Investigation, 79, 867, 10.1172/JCI112896 · DOI · Paper page
  32. Solanki D.L., 1985, American Journal of Hematology, 20, 353, 10.1002/ajh.2830200406 · DOI
  33. Sultana C., 1998, Blood, 10, 3924, 10.1182/blood.V92.10.3924 · DOI · Paper page
  34. Swerlick R.A., 1993, Blood, 82, 1891, 10.1182/blood.V82.6.1891.1891 · DOI · Paper page
  35. Taylor S.C., 1989, Journal of the National Medical Association, 89, 753
  36. Taylor S.C., 1990, Lymphokine Research, 9, 415
  37. Tomer A., 1992, Blood, 80, 11
  38. Tomer A., 1994, Blood, 84, 412
  39. Vilela M.M., 1990, Journal of Tropical Pediatrics, 36, 266, 10.1093/tropej/36.5.266-a · DOI
  40. Vilela M.M., 1989, Brazilian Journal of Medical and Biological Research, 22, 725
  41. Weyrich A.S., 1996, Journal of Clinical Investigation, 97, 1525, 10.1172/JCI118575 · DOI · Paper page
  42. Wun T., 2001, Hematology, 5, 403, 10.1080/10245332.2000.11746536 · DOI
  43. 10.1046/j.1365-2141.1998.00627.x · DOI · Paper page
  44. 10.1016/S0022-2143(97)90005-6 · DOI · Paper page

Cited by

See all 130

Metadata

Authors
Wun, T., CORDOBA, M., Rangaswami, A. A., Cheung, A., & Paglieroni, T. G.
Venue
Clinical & Laboratory Haematology
Publisher
Wiley
Published
2002-04
Volume
24
Issue
2
Pages
81-88
ISSN
  • 0141-9854 (ISSN-L)
  • 1365-2257
OpenAlex
W2052525169
Cited by
130
References
4
FWCI
2.95
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1 (tdm, 4901 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*. https://app.cochat.ai/papers/10.1046/j.1365-2257.2002.00433.x
The paper
Wun, T., CORDOBA, M., Rangaswami, A. A., Cheung, A., & Paglieroni, T. G. (2002). Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*. Clinical & Laboratory Haematology. https://doi.org/10.1046/j.1365-2257.2002.00433.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.